Clinical Outcome After Implantation of Two Different Multifocal Toric IOLs: Liberty (677MTY) and PanOptix®
Comparison of Clinical Outcome After Implantation With Two Different Multifocal Toric Intraocular Lens: Liberty Trifocal 677MTY (Medicontur) and PanOptix® Multifocal Toric (Alcon) Lens, With Respect to Rotational Stability, Visual Outcomes, Patients' Satisfaction, YAG Capsulotomy Rate
1 other identifier
observational
35
1 country
1
Brief Summary
This study is to compare the rotational stability, visual outcome and patient satisfaction after implantation with either Liberty 677MTY, a multifocal diffractive-refractive IOL based on EPS technology manufactured by Medicontur Ltd. (Zsámbék, Hungary) or the multifocal toric IOL PanOptix®, manufactured by Alcon.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 14, 2020
CompletedFirst Submitted
Initial submission to the registry
December 17, 2020
CompletedFirst Posted
Study publicly available on registry
June 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 10, 2024
CompletedAugust 30, 2024
August 1, 2024
3.7 years
December 17, 2020
August 28, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Rotational stability
Rotational stability will be measured using slit lamp images of the implanted lens
Day 1
Rotational stability
Rotational stability will be measured using slit lamp images of the implanted lens
3 months
Rotational stability
Rotational stability will be measured using slit lamp images of the implanted lens
1 year
Secondary Outcomes (10)
Visual outcome (UDVA, CDVA, UIVA, DCIVA, UNVA, DCNVA)
1 month
Visual outcome (UDVA, CDVA, UIVA, DCIVA, UNVA, DCNVA)
3 months
Visual outcome (UDVA, CDVA, UIVA, DCIVA, UNVA, DCNVA)
1 year
Contrast sensitivity defocus curve
3 months
Contrast sensitivity defocus curve
1 year
- +5 more secondary outcomes
Other Outcomes (3)
Safety outcome - Intraoperative complications
Day1 postoperatively
Safety outcome - Postoperative complications
Month1 postoperatively
Safety outcome - Complications of IOL implantation
Month 12 postoperatively
Study Arms (2)
Liberty
The group implanted with Liberty 677MTY
PanOptix
The group implanted with PanOptix
Eligibility Criteria
Patients with cataract
You may qualify if:
- The enrolled subjects will be the patients with cataract and pre-existing regular corneal astigmatism between 1.0 to 6.0 dpt.
You may not qualify if:
- astigmatism less than 1 dpt
- irregular astigmatism
- diabetic retinopathy
- iris neovascularisation
- serious intraoperative complications
- congenital eye abnormality
- glaucoma
- pseudoexfoliation syndrom
- amblyopia
- uveitis
- long-term anti-inflammatory treatment
- AMD (advanced AMD)
- retinal detachment
- prior ocular surgery in personal medical history
- corneal diseases
- +8 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Retinaszervíz
Veszprém, 8200, Hungary
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
József F Győry, MD
Retinaszerviz Kft. (8200 Veszprém, Vörösmarty tér 6, Hungary)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 17, 2020
First Posted
June 8, 2023
Study Start
September 14, 2020
Primary Completion
May 10, 2024
Study Completion
May 10, 2024
Last Updated
August 30, 2024
Record last verified: 2024-08